| 694338 |
FRONTIERS IN ONCOLOGY |
The Value of MR-DWI and T1 Mapping in Indicating Radiation-Induced Soft Tissue Injury |
2021-05-27 |
10.3389/fonc.2021.651637 |
Wang Zeng, Xiong Bowen, Kang Nannan, Pan Xiaoxian, Wang Caihong, Su Li, Xing Zhen, Hong Jinsheng |
| 694337 |
FRONTIERS IN ONCOLOGY |
Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy |
2021-05-27 |
10.3389/fonc.2021.640910 |
Hu Li, Cheng Xingbo, Binder Zev, Han Zhibin, Yin Yibo, O’Rourke Donald M., Wang Sida, Feng Yumeng, Weng Changjiang, Wu Anhua, Lin Zhiguo |
| 694336 |
FRONTIERS IN ONCOLOGY |
Absolute Lymphocyte Count Predicts Immune-Related Adverse Events in Patients With Non-Small-Cell Lung Cancer Treated With Nivolumab Monotherapy: A Multicenter Retrospective Study |
2021-05-27 |
10.3389/fonc.2021.618570 |
Egami Saeka, Kawazoe Hitoshi, Hashimoto Hironobu, Uozumi Ryuji, Arami Toko, Sakiyama Naomi, Ohe Yuichiro, Nakada Hideo, Aomori Tohru, Ikemura Shinnosuke, Fukunaga Koichi, Yamaguchi Masakazu, Nakamura Tomonori |
| 694335 |
FRONTIERS IN ONCOLOGY |
MET and FASN as Prognostic Biomarkers of Triple Negative Breast Cancer: A Systematic Evidence Landscape of Clinical Study |
2021-05-27 |
10.3389/fonc.2021.604801 |
Jiang Weihua, Xing Xiao-Liang, Zhang Chenguang, Yi Lina, Xu Wenting, Ou Jianghua, Zhu Ning |
| 694334 |
FRONTIERS IN ONCOLOGY |
Association of PTPRD/PTPRT Mutation With Better Clinical Outcomes in NSCLC Patients Treated With Immune Checkpoint Blockades |
2021-05-27 |
10.3389/fonc.2021.650122 |
Wang Xiaoyan, Wu Bingchen, Yan Zhengqing, Wang Guoqiang, Chen Shiqing, Zeng Jian, Tao Feng, Xu Bichun, Ke Honggang, Li Mei |
| 694333 |
FRONTIERS IN ONCOLOGY |
Treating Bladder Cancer: Engineering of Current and Next Generation Antibody-, Fusion Protein-, mRNA-, Cell- and Viral-Based Therapeutics |
2021-05-27 |
10.3389/fonc.2021.672262 |
Bogen Jan P., Grzeschik Julius, Jakobsen Joern, Bähre Alexandra, Hock Björn, Kolmar Harald |
| 694332 |
FRONTIERS IN ONCOLOGY |
Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators |
2021-05-27 |
10.3389/fonc.2021.659754 |
Byun Hwa Kyung, Chang Jee Suk, Jung Minkyu, Koom Woong Sub, Chung Kee Yang, Oh Byung Ho, Roh Mi Ryung, Kim Kyung Hwan, Lee Choong-Kun, Shin Sang Joon |
| 694331 |
FRONTIERS IN ONCOLOGY |
Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma |
2021-05-27 |
10.3389/fonc.2021.601668 |
Lei Yongrong, Wang Xishu, Sun Heng, Fu Yuna, Tian Yichen, Yang Ludi, Wang Jianhua, Xia Feng |
| 694330 |
FRONTIERS IN ONCOLOGY |
Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients |
2021-05-27 |
10.3389/fonc.2021.665870 |
Lei Kunjian, Li Jingying, Tu Zewei, Liu Feng, Ye Minhua, Wu Miaojing, Zhu Yue, Luo Min, Lin Li, Tao Chuming, Huang Kai, Zhu Xingen |
| 694329 |
FRONTIERS IN ONCOLOGY |
Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer |
2021-05-27 |
10.3389/fonc.2021.659987 |
Ji Xiaoqin, Zhao Yulu, He Chenglong, Han Siqi, Zhu Xixu, Shen Zetian, Chen Cheng, Chu Xiaoyuan |
